To view this email as a web page, click here.
FROM THE CANCER NETWORK
 
FDA Approves First Gene Therapy for Pediatric Leukemia
The US Food and Drug Administration has approved the first gene therapy available in the United States, tisagenlecleucel (Kymriah; Novartis), for the treatment of pediatric and young adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
Find out more
 
FROM CONTEMPORARY PEDIATRICS
 
An app for assessing neonatal jaundice? You bet!
A study of the accuracy of a technology for assessing jaundice in outpatient neonates based on analysis of digital images demonstrated that this smartphone application (app) may be useful for screening newborns for jaundice.
Find out more
 
 
Influence of social media on teenagers' body image
Visually oriented social media platforms created by their peers can have a significant negative impact on adolescents’ body image.
Find out more
Annual advocacy award
 
Nominate a hero for our 2017 advocacy award!
Contemporary Pediatrics wants to hear about any pediatrician making meaningful change to improve patient well-being or transforming his or her community into a healthier place for children. Please nominate your pediatric child advocacy hero. Nominations are open until December 15, 2017.
 
CONTEMPORARY PEDIATRICS VIDEO
 
Does pediatric psoriasis increase cancer risk?
image description here For Contemporary Pediatrics, Dr Bobby Lazzara discusses a large retrospective cohort study published in the Journal of the American Academy of Dermatology that examined whether children with pediatric psoriasis are at increased risk of cancer and discusses 2 caveats to the findings.
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.